Pfizer is doubling down on obesity treatments by spending $4.9 billion on the development-stage drugmaker Metsera Pfizer is doubling down on obesity treatments by spending $4.9 billion on the ...

Five months after ending development of its own obesity treatment, Pfizer is accelerating its push into the rapidly growing field with a nearly $5 billion acquisition. Google’s Play Store shake-up ...

Five months after ending development of its own obesity treatment, Pfizer is accelerating its push into the rapidly growing field with a nearly $5 billion acquisition. The COVID-19 vaccine and ...

Select an option below to continue reading this premium story. Already a Honolulu Star-Advertiser subscriber? Log in now to continue reading. “You are the builders of a new chapter in the Hawaiian ...

Five months after ending development of its own obesity treatment, Pfizer is accelerating its push into the rapidly growing field with a nearly $5 billion acquisition. 13 states that don’t tax your ...

A reported €1bn carrot for Spain, a €14.5bn stick for Luxembourg, lobbying by Hungary and Slovakia, anti-EU lawsuits, and media spin, as Russian billionaire Mikhail Fridman tries to get off Europe's ...

Five months after ending development of its own obesity treatment, Pfizer is accelerating its push into the rapidly growing field with a nearly $5 billion acquisition. Baltimore-founded drug maker, ...

Internet security researchers work on building a cyber reasoning system that uses AI to detect and fix vulnerabilities in open-source software. Photo / Philip Cheung, for The Washington Post While ...

AMP has settled on two court proceedings: one class action which affected superannuation members and a second regarding insurer policies. In two separate ASX announcements on 15 September, the firm ...

Should you buy AMP shares? Here are some new expert ratings post-earnings season. The ASX 200 financial share has leapt 33% higher in just six months. AMP shares hit a five-year high of $1.90 last ...